Bio-Techne Corp (TECH) Financials
TECH Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 2.7 billion | 767.2 million |
2023-09-30 | 2.8 billion | 757.6 million |
2023-06-30 | 2.6 billion | 672.2 million |
2023-03-31 | 2.6 billion | 710.0 million |
TECH Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 68.3 million | 12.8 million |
2023-09-30 | 45.8 million | 10.1 million |
2023-06-30 | 72.6 million | -2.1 million |
2023-03-31 | 38.8 million | 10.1 million |
TECH Net Income
Date | Net Income |
---|---|
2023-12-31 | 27.5 million |
2023-09-30 | 51.0 million |
2023-06-30 | 75.5 million |
2023-03-31 | 70.2 million |
TECH Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 135.7 million | - | 108.7 million |
2023-09-30 | 148.7 million | - | 109.5 million |
2023-06-30 | 204.3 million | 350.0 million | 105.0 million |
2023-03-31 | 157.2 million | 370.0 million | 104.0 million |
TECH Shares Outstanding
TECH Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 14.9 million | 22.9 million | 115.7 million | - |
2023-09-30 | 13.6 million | 24.0 million | 105.3 million | - |
2023-06-30 | 10.8 million | 23.4 million | 86.8 million | - |
2023-03-31 | 11.7 million | 22.7 million | 99.2 million | - |
TECH Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 272.6 million | 96.0 million |
2023-09-30 | 276.9 million | 91.7 million |
2023-06-30 | 301.3 million | 96.6 million |
2023-03-31 | 294.1 million | 92.0 million |
TECH
Price: $64.06
Dividend Yield: 0.00%
Forward Dividend Yield: 0.50%
Payout Ratio: 23.02%
Dividend Per Share: 0.32 USD
Earnings Per Share: 1.39 USD
P/E Ratio: 47.47
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 837800
Ebitda: 39.7 millionMarket Capitalization: 10.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 17
DGR3: 30.00%
DGR5: 20.00%
DGR10: 11.00%